Alex Delaney-Gesing

Articles

MeiraGTx reports Fast Track designation by FDA for gene therapy candidate to treat ACHM

January 26, 2021

Article

The FDA has granted Fast Track designation to MeiraGTx's AAV-CNGA3 gene therapy product candidate for the treatment of achromatopsia (ACHM).

What keeps ophthalmologists up at night (Part III)

January 20, 2021

Video

From patient care and treating glaucoma to the ongoing pandemic, ophthalmologists share the most pressing thoughts of concern leaving them awake at night.

Amydis announces successful pre-IND meeting with FDA to develop retinal tracer for amyloid angiopathy diagnosis

January 11, 2021

Article

Amydis announced the successful completion of a pre-investigational new drug (IND) meeting with the FDA for its candidate AMDX-2011P, a small-molecule retinal tracer that targets amyloid beta to diagnosis amyloid angiopathy.

Analyzing an investigational ophthalmic solution for treating presbyopia-related symptoms

December 13, 2020

Video

Michael R. Robinson, MD, Allergan, discusses the results from a study analyzing an investigational ophthalmic solution for treatment of symptoms associated with presbyopia presented during the virtual AAO 2020 meeting.